Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.A novel ...
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...
SG Americas Securities LLC decreased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 17.9% during the 4th quarter, according to the company in its most recent disclosure with the ...